Testing effectiveness (Phase 2)Not Yet RecruitingNCT07647029
What this trial is testing
A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae
Who this might be right for
Breast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT)
Fudan University 126